AKT1 and Miyoshi myopathy: Targeting Ras/MAPK and/or PI3K/AKT in canine MM has been shown to inhibit specific target signal transduction while inducing cell death and cell cycle arrest and suppressing tumor growth and metastasis in mouse xenograft models [24].